Pipeline

Pineline Overview

Platfrom
Program
Active Substance
Disease
R&D
Non-Clinical
Phase 1
Phase 2
Albubody
PAT301
PAT401
Albubody-
Drug conjugate
LYTACs
Anti-Cancer
Anti-Cancer

Open Innovation

Platfrom
Program
Active Substance
Disease
SelecAll™
PAT101
PAT205/206
Uox-HSA
(Urate Oxidase)
GLP1
Refrctory
Tophaceous Gout
Obesity
Albubody™
PAT301
PAT401
Albubody-
Drug conjugate
LYTACs
Anti-Cancer
Anti-Cancer
R&D
Non-Clinical
Phase 1
Phase 2

Open Innovation

Open Innovation